Top stories
![With reports that Formula One race organisers are considering scrapping or relocating several Middle Eastern races this year due to heightened security concerns, the events industry is once again confronting the reality of operating in an unpredictable world (Image source: @ Scuderia Ferrari Club https://sfcriga.com/ Scuderia Ferrari Club]])](https://biz-file.com/c/2603/806699-300x156.jpg?1)
Marketing & MediaEvent organisers need a mindset of resilience as global instability shapes the events landscape
23 Mar 2026
Trending
Subscribe & Follow
Advertise your job vacancies
Insulin pens launched
In January 2008, sanofi aventis officially launched a new disposable pen for its LANTUS® and APIDRA® insulin. Named SoloSTAR®, the device was sampled firsthand by doctors who attended the events countrywide.
Dr. David Seagal gave a presentation to at the Johannesburg launch of SoloSTAR®.
SoloSTAR® is an easy-to-use disposable insulin pen that uses 30% less force when injecting – in comparison with other leading brands. It also boasts the highest dose range of disposable pens with a single dose of up to 80 units, adjustable in 1 unit steps.
SoloSTAR® is available for use with LANTUS®, the number 1 basal insulin analogue sold worldwide with a once-daily 24-hour action profile, and the rapid acting insulin analogue APIDRA®, which offers a faster onset of action and a shorter duration of action than regular human insulin.
Unique to the SoloSTAR® range is the colour coding of pens for each insulin. The LANTUS ® pens are purple worldwide, whereas the APIDRA ® pens are grey. Both of which are currently available in South Africa.
